Catalysis SL   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Madrid Spain (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2009
NCT01025115
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Catalysis SL | INOR